According to a TechSci Research report, “PCOS Diagnostic Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F”, the global PCOS diagnostic market is anticipated to grow at a steady rate in the forecast period of 2024-2028. This can be ascribed to the growing number of PCOS cases across the world. PCOS is the most common endocrine disorder among women of reproductive age (15-49 years). According to the Centers for Disease Control & Prevention (CDC) May 2022 report, PCOS is the most common cause of infertility among women.
The National Institute of Child Health and Human Development (NICHD)/National Institutes of Health (NIH)/European Society of Human Reproduction and Embryology (ESHRE)/American Society for Reproductive Medicine (ASRM) accompanied by the Androgen Excess Society (AES) Criteria (2006) provided a diagnostic criterion for PCOS including Hyperandrogenism, Oligo-ovulation/anovulation, Polycystic ovaries and exclusion of other related disorders as factors to be met for the diagnosis of PCOS.
Besides, sudden outbreak and spread of pandemic COVID-19 has increased the count for PCOS patients. As it is a symptomatic illness, the physical and mental health of women affected by the COVID-19 epidemic and the associated lockdown procedures was highly negative. Therefore, the pandemic and its associated restrictions had a disproportionately negative effect on women who typically received care from various main and specialist healthcare facilities.
One of the primary factors driving market expansion in North America is the rise in PCOS cases caused by the prevalence of obesity and overweight people. Obesity being considered a major risk factor for PCOS has seen a surge during the pandemic. According to a report (September 2020) supplied by the Centers for Disease Control and Prevention (CDC), adult obesity prevalence is rising as a result of work-from-home culture, a decline in physical activity levels, and an increase in food consumption. The data by CDC revealed that there is a high prevalence of obesity in North American countries (~35%), which is going to increase the risk of PCOS and is anticipated to offer growth to the market.
Also, there have been several initiatives by private and government firms to increase awareness about the disease, which is also expected to drive the market. For instance, on 30th April, 2016, in India, National Institute for Research in Reproductive Health (NIRRH) inaugurated a multidisciplinary clinic_ PCOS Clinic. The PCOS clinic – is first of its kind in India, it is inaugurated as a support from the Government of India and is currently serving as a common platform where services and research meet. In the center, women with PCOS will receive holistic management from a multidisciplinary team of infertility specialists, dermatologists, psychiatrists, nutritionists, and yoga instructors.
However, this high incidence and its connection to ovulation and menstruation abnormalities, infertility, hair loss, and metabolic difficulties emphasize the significant financial burden caused by PCOS and could therefore restrain the global PCOS diagnostic market over the course of the projected period.
Browse over XX market data Figures spread through XX Pages and an in-depth TOC on “PCOS Diagnostic Market” – https://www.techsciresearch.com/report/pcos-diagnostic-market/14692.html
The global PCOS diagnostic market can be segmented by the type of test, by end-user, and by region. Based on Test Type Channel, the Global PCOS Diagnostic Market can be segmented into Blood Test, Pelvic Exam, and Ultrasound (Transvaginal). The Transvaginal Ultrasound segment dominated the market in 2022. This was due to ultrasound being the most acceptable test to be performed to get a clear idea of the PCOS affected ovarian morphology by capturing an ultrasound image of the vagina and thereby enabling the patient for further treatment. Besides, the transvaginal ultrasound provides an ultrasound image of a woman’s uterus, ovaries, tubes, cervix and pelvic area and thus can be used for acknowledging the health and degree of illness among the organs, thus analyzing the PCOS prevalence status.
Based on end-user, the Global PCOS Diagnostic Market can be segmented into hospital & clinics, fertility clinics, and others. The hospital & clinics segment is dominating the market in 2022 and will maintain its dominance throughout the forecast period. This can be attributed to the growing number of patient admissions in these facilities suffering from various symptoms leading to PCOS. Generally, patients’ traction is more in Hospitals & Clinics as most women suffering from symptoms related to PCOS visit common physicians, dermatologists, endocrinologists, infertility experts and gynecologists available in the Hospital & Clinics premises for diagnosis.
Major companies operating in the Global PCOS Diagnostic Market are:
- Siemens Healthineers AG
- GE Healthcare
- Mindray Medical International Limited
- Esaote S.p.A
- Telemed Medical Systems
- Shantou Institute of Ultrasonic Instruments Co., Ltd. (SIUI)
- BK Medical
- Alpinion Medical Systems
- Mindray ZONARE Medical Systems
- Xianfeng Ultrasound Medical
Companies operating in the market are following strategies such as continuously innovating tools to improve image quality and create specialized clinical tools to help the patients see more anatomical detail with greater certainty, enabling them to provide the best possible patient care, in order to stay competitive and have an edge over other players operating in the industry.
Customers can also request for 10% free customization on this report.
“North America is expected to dominate in the Global PCOS Diagnostic Market during the forecast period on account of increasing prevalence of PCOS. Besides, increasing healthcare expenditure and flourishing healthcare industry in the region are further expected to support the market growth in the region” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“PCOS Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F, Segmented By Test Type (Blood Test, Pelvic Exam, Ultrasound Transvaginal)), By End User (Hospital & Clinics, Fertility Clinics, Others), and CompetitionBy Region”, has evaluated the future growth potential of Global PCOS Diagnostic Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global PCOS diagnosis market.
Table Of Content
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Clinical Trial Analysis
5.1. Ongoing Clinical Trials
5.2. Completed Clinical Trials
5.3. Terminated Clinical Trials
5.4. Breakdown of Pipeline, By Development Phase
5.5. Breakdown of Pipeline, By Status
5.6. Breakdown of Pipeline, By Study Application
5.7. Breakdown of Pipeline, By Region
5.8. Clinical Trials Heat Map
………………………………. continued
Download Free Sample Report – https://www.techsciresearch.com/sample-report.aspx?cid=14692
About TechSci Research:
TechSci Research is a research-based management consulting firm providing market research and advisory solutions to its customers worldwide, spanning a range of industries. TechSci Research’s core values are value, integrity and insight. Led by a team of dynamic industry experts, TechSci Research provides its customers with high value market research and advisory services that helps them identify new market opportunities, growth engines and innovative ways to capture the market share. As a result, TechSci’s client leads rather than follow market trends. Not bound by legacy, TechSci’s cutting-edge research model leverages its decades of research knowledge and an increased use of technology as engines of innovation to deliver unique research value. Provided as an alternative to traditional market research, TechSci Research reports do not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]